Lifeward (LFWD) Return on Capital Employed Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1,962.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 31.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -846.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,318.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -247.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 362.00 |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn | -11,524.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11,524.00 |
| Dec 31, 2025 | -15,267.00 |
| Sep 30, 2025 | -16,442.00 |
| Jun 30, 2025 | -15,302.00 |
| Mar 31, 2025 | -11,892.00 |
| Dec 31, 2024 | -9,152.00 |
| Sep 30, 2024 | -3,796.00 |
| Jun 30, 2024 | -4,059.00 |
| Mar 31, 2024 | -2,825.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 3,278.00 |
| Jun 30, 2023 | 4,975.00 |
| Mar 31, 2023 | 6,911.00 |
| Dec 31, 2022 | 6,028.00 |
| Sep 30, 2022 | -1,985.00 |
| Jun 30, 2022 | -762.00 |
| Mar 31, 2022 | 1,547.00 |
| Dec 31, 2021 | 4,839.00 |
| Sep 30, 2021 | 59,905.00 |
| Jun 30, 2021 | 33,309.00 |
| Mar 31, 2021 | 20,944.00 |
| Dec 31, 2020 | 12,330.00 |
| Sep 30, 2020 | 10,985.00 |
| Jun 30, 2020 | 12,179.00 |
| Mar 31, 2020 | 9,180.00 |
| Dec 31, 2019 | 13,256.00 |
| Sep 30, 2019 | 24,170.00 |
| Jun 30, 2019 | 14,937.00 |
| Mar 31, 2019 | 9,277.00 |
| Dec 31, 2018 | 3,894.00 |
| Dec 31, 2017 | -13,820.00 |